Highlights

The National Institute of Neurological Disorders and Stroke awarded $644,814 to the University of Arizona on July 6, 2026, to fund research into tau protein variants in FUS-mediated ALS, a genetic form of amyotrophic lateral sclerosis driven by mutations in the FUS gene.

Principal investigator Haining Zhu will lead the project, titled "Tau variants in FUS-mediated ALS," under NIH project number 1R01NS144500-01A1. The grant runs through June 30, 2031.

The $644,814 award is a first-year R01, a standard NIH investigator-initiated research grant. The project period spans five years, from July 6, 2026, through June 30, 2031.

The award is one of several NIH grants flowing to the University of Arizona in the same funding cycle. A separate $562,733 grant from the National Heart Lung and Blood Institute to principal investigator Hossein Ardehali targets small molecule therapeutics for heart failure, also beginning July 6, 2026. A $578,565 award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to principal investigator Taejeong Song, studying skeletal myosin binding protein in distal arthrogryposis, began July 10, 2026.

The NIH Reporter detail page for project 1R01NS144500-01A1 is expected to carry the full abstract as the award record matures.

Sources

Every factual claim in this article traces to one of the sources below. See how we work for the editorial process.

  1. reporter.nih.gov retrieved 12/07/2026 21:35
  2. reporter.nih.gov retrieved 12/07/2026 21:35
  3. reporter.nih.gov retrieved 12/07/2026 21:35

Authored by The Scottsdale Signal. Drafted by AI from primary-source material under our beat-specific editorial guides; reviewed by humans before publish under our five-gate process. Sources retrieved at 12/07/2026 21:35. Every claim traces to a source.